Ying‐Erh Chou
Papers
1
Total Citations
15
H-Index
1
About
Dr. Ying‐Erh Chou has made significant contributions to the molecular epidemiology of urological cancers, with a particular focus on prostate cancer. Her research centers on the role of long noncoding RNAs (lncRNAs) and genetic polymorphisms in cancer susceptibility, progression, and prognosis. In her highly cited 2021 study, she investigated associations between lncRNA MALAT1 polymorphisms and lymph node metastasis in prostate cancer, demonstrating how single-nucleotide polymorphisms (SNPs) in this oncogenic lncRNA can alter disease outcomes. This work, which has garnered 15 citations, highlights her expertise in integrating genetic variation with functional genomics to uncover biomarkers for cancer risk stratification. Dr. Chou’s research has advanced the understanding of how noncoding RNAs influence tumor behavior, offering potential avenues for personalized prognosis and targeted therapy. Her findings are particularly impactful for clinicians and researchers working on precision oncology in prostate cancer, where identifying genetic markers of metastasis remains a critical challenge. Through her rigorous approach, Dr. Chou continues to shape the landscape of cancer genetics and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1